IDH-C227
Product Specifications
UNSPSC Description
IDH-C227 is a potent and selective IDH1R132H inhibitor. IDH-C227 has anticancer effcts[1].
Target Antigen
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/idh-c227.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(NCC(N(C(C2=C(C)C=CC=C2)C(NC3CCCCC3)=O)C4=CC(F)=CC=C4)=O)C=C1
Molecular Weight
498.59
References & Citations
[1]Hanumantha Rao Madala, et al. Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies. Cancers (Basel). 2018 Feb 11;10(2):49.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-136686/IDH-C227-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-136686/
Clinical Information
No Development Reported
CAS Number
1355324-14-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
